9 pending office actions • 6 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Carrygenes Bioengineering, LLC | 4 |
| Relevance Health | 1 |
| K-Gen Therapeutics, Inc. | 1 |
| Ferro Therapeutics, Inc. | 1 |
| K-Gen, Inc. | 1 |
| Xerxez Calilung | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19051210 | System for Assessing Global Wellness | Relevance Health | ELSHAER, ALAAELDIN M | 3687 | Non-Final OA | Feb 12, 2025 |
| 18520555 | LINEAGE REPORTER SYNTHETIC CHROMOSOMES AND METHODS OF USE | Carrygenes Bioengineering, LLC | QIAN, CELINE X | 1637 | Final Rejection | Nov 28, 2023 |
| 18283787 | DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC) | K-Gen Therapeutics, Inc. | PATEL, SAGAR S | 1626 | Non-Final OA | Sep 23, 2023 |
| 18217601 | SYNTHETIC CHROMOSOMES EXPRESSING BIOSYNTHETIC PATHWAYS | Carrygenes Bioengineering, LLC | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Jul 02, 2023 |
| 18023270 | COMPOUNDS AND METHODS OF USE | Ferro Therapeutics, Inc. | HEASLEY, MEGHAN CHRISTINE | 1626 | Non-Final OA | Feb 24, 2023 |
| 17763611 | DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC) | K-Gen, Inc. | HIRAKIS, SOPHIA P | 1623 | Final Rejection | Mar 24, 2022 |
| 17630862 | COMPOSITIONS AND METHODS OF USING MULTIPOTENT STEM CELLS TO REDUCE DISEASE AND ENHANCE WELLNESS | Xerxez Calilung | TICHY, JENNIFER M.H. | 1653 | Final Rejection | Jan 27, 2022 |
| 17582609 | Methods of Cell Renewal | Carrygenes Bioengineering, LLC | REGLAS, GILLIAN CHELSEA | 1632 | Non-Final OA | Jan 24, 2022 |
| 17482307 | COMPOSITIONS AND METHODS FOR MONITORING IN REAL-TIME CONSTRUCTION AND BIOENGINEERING OF MAMMALIAN SYNTHETIC CHROMOSOMES | Carrygenes Bioengineering, LLC | LEITH, NANCY J | 1636 | Non-Final OA | Sep 22, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial